Navigation Links
Inbreeding May Have Doomed Spain's Habsburg Dynasty
Date:5/9/2009

Enfeebled and sterile, Charles II's genes made him the last of his line, researchers say

FRIDAY, May 8 (HealthDay News) -- Members of the powerful Habsburg royal family ruled Spain for centuries until the dynasty died out at the beginning of the 18th century.

Now, a new study suggests the reason for their decline lies not in the stars but in themselves -- and their unfortunate habit of marrying their own relatives.

Ultimately, the genetic havoc caused by inbreeding appears to have doomed the Spanish Habsburgs to oblivion via infertility, scientists report in a research paper released last month.

"Inbreeding was a major cause responsible for the extinction of this dynasty" and also contributed to the deaths of many Habsburg children, said study co-author Francisco C. Ceballos, a researcher at the Universidad de Santiago de Compostela in Spain.

The study suggests that successive inbreeding contributed to the genetic diseases that turned the last Habsburg king, Charles II, into a mental and physical cripple who was unable to have children. Charles II reigned from 1665 until his death in 1700 at the age of 38.

The findings appear in a recent issue of the journal PLoS ONE.

Today, the Habsburgs are most well known for their domination of Europe over three centuries -- Charles II ruled not only Spain but Italy and much of what is now the Netherlands -- and for their oddly protruding jaws.

In Spain, the Habsburgs ruled from 1516 until 1700, when Charles II died without offspring, despite two marriages.

The family faced a challenge because they needed to marry Catholic spouses of equal rank -- a rarity -- and because dynastic marriages were used to keep territories within the family's grasp, explained Alan Sked, a historian at the London School of Economics and Political Science.

In their study, Ceballos and colleagues examined the Habsburg family tree through more than 3,000 people, going back 16 generations. They aimed to figure out how inbreeding -- cousins marrying cousins, for example, and uncles marrying nieces -- may have affected the family's health.

The team found that the final Habsburg ruler, Charles II, had a high chance of developing genetic abnormalities due to inbreeding. Indeed, he was physically stunted and suffered from a variety of intestinal and blood ailments, so much so that his subjects dubbed him "El Hechizado," or "The Hexed."

The study also suggests that interbreeding weakened the family's health so much that it contributed to an extraordinarily high death rate among children. From 1527-1661, 10 of 34 children in the Spanish Habsburg family died before the age of 1, and another seven died before they were 10. The researchers note that the death rate was much higher than would even be expected for children born in that era.

Overall, the Habsburgs' habit of inbreeding led to family members sharing up to 20 percent of identical genomic material, the researchers said.

The conclusion that inbreeding may have hurt the Habsburg family's health is a reasonable one because the odds of genetic disease rise when people marry their relatives, according to Andrew J. Bohonak, an associate professor of biology at San Diego State University.

Possibly as a result, "there are social taboos against inbreeding in most human societies," he said. "One of the few places you see these taboos avoided is in some of the royal families of old."

What would have happened if the Habsburgs hadn't married each other? Sked, the historian, said "there would have been changes in alliances, boundaries and policies. Most of all, the Habsburgs would have produced more capable and intelligent rulers."

More information

Learn more about the Habsburgs from the Encarta encyclopedia.



SOURCES: Francisco Camina Ceballos, Departamento de Fisiologia Facultad de Medicina, Universidad de Santiago de Compostela, A Coruna, Spain; Andrew J. Bohonak, Ph.D., associate professor, San Diego State University; and Alan Sked, Ph.D., historian, London School of Economics and Political Science, U.K.; April 2009, PLoS ONE


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Why Are Most Health & Wellness Products Doomed to Failure?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Inbreeding May Have Doomed Spain's Habsburg Dynasty
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Offering the ... with an oil many times purer and more potent than the market has seen ... of Gstaad, Switzerland, as well as a patented chromatography process for extraction, to produce ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... in hospitals, today announced it has completed a round of funding to accelerate ... and its partners. Black Granite Capital is a growth equity firm focused on ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... the ATA 2017 President’s Awards recipients, comprised of organizations and individuals who ... , The ATA 2017 President’s Awards recognize individuals and organizations on ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, president and CEO ... Enterprising Women magazine as one of its 2017 Enterprising Women of the Year, ... have demonstrated that they have fast-growth businesses, mentor or actively support other women ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... Miami native ... as a dentist. , “I could have never imagined back in 1991 that this ... said Dr. Gallardo. , Over the last 25 years, Dr. Gallardo has pioneered implant ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology: